Larvol Delta - Asher-Bio-Announces-Clinical-Trial-Collaboration-with-Merck-to-Evaluate-AB248-in-Combination-with-KEYTRUDA-pembrolizumab-in-Patients-with-Locally-Advanced-or-Metastatic-Solid-Tumors

AB248 - Asher Biotherap

Keytruda (pembrolizumab) - Merck (MSD)

https://www.businesswire.com/news/home/20220601005077/en/Asher-Bio-Announces-Clinical-Trial-Collaboration-with-Merck-to-Evaluate-AB248-in-Combination-with-KEYTRUDA%C2%AE-pembrolizumab-in-Patients-with-Locally-Advanced-or-Metastatic-Solid-Tumors

Jun 1, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next